SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-112062
Filing Date
2022-04-21
Accepted
2022-04-21 07:02:01
Documents
5
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A d279732ddef14a.htm DEF 14A 409184
2 GRAPHIC g279732dsp001.jpg GRAPHIC 141449
3 GRAPHIC g279732dsp002.jpg GRAPHIC 125014
4 GRAPHIC g279732g70x82.jpg GRAPHIC 24406
5 GRAPHIC g279732g88z98.jpg GRAPHIC 51620
  Complete submission text file 0001193125-22-112062.txt   879021
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37813 | Film No.: 22839646
SIC: 2834 Pharmaceutical Preparations